Charité

Our most important university partner for translational research activities is the Charité - Universitätsmedizin Berlin.

 

Since 2007, the two institutions have jointly run the experimental and clinical research center (ECRC), a center for translational medicine on the Campus Buch. The Max Delbrück Center and the Charité have extended their joint activities even further by forming the Berlin Institute of Health (BIH), which is focusing on translational systems medicine research.

Article

Scientific image
Science

Gut microbiome reveals risk of organ rejection

A team of researchers in the lab of Dr. Nicola Wilck at the Experimental and Clinical Research Center in Berlin have found that changes in gut microbes can indicate that the body may reject a transplanted kidney. The study was published in the “American Journal of Transplantation.”
Peter M. Schlag
Institute & Campus

In memory of Professor Peter M. Schlag

The Max Delbrück Center mourns the loss of Professor Peter M. Schlag (1948–2025). He was a pioneer of cancer research and a passionate physician. Schlag worked as a group leader at our research center for more than two decades.
scientific image
Press Release No. 5 Berlin

Inflammatory messenger fuels Alzheimer’s

Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer’s disease. The study was published in the journal “Nature Aging.”
Scientific image
Science

New treatment approach for rare blood cancer of the skin

Researchers from Medical University of Vienna, Charité Berlin and Max Delbrück Center have identified the CD74 protein as a new drug target to treat deadly skin lymphoma. The study was published in the “British Journal of Dermatology.”
Gabriele Schiattarella
Science

Gabriele Schiattarella awarded W2 Professorship

Dr. Gabriele G. Schiattarella has been awarded a W2 Professorship for Cardiometabolic Diseases at the Deutsches Herzzentrum der Charité. He will continue to study one of the biggest challenges in cardiology: heart failure with preserved ejection fraction.
Philipp Jan Junker
Institute & Campus

Professorship awarded to Jan Philipp Junker

Jan Philipp Junker’s new full professorship at Charité Universitätsmedizin Berlin will enable him to push the boundaries of tissue regeneration research. Using single-cell sequencing, microscopy and genetics, he hopes to unlock ways to enhance organ regeneration in mammals.
Scientific image
Press Release No. 4 Berlin

Not all heart inflammation is the same

A group of Berlin researchers in collaboration with international scientists have found differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccination, and non-COVID-19 myocarditis. The find paves the way for more personalized therapies, they report in “Nature Cardiovascular Research.”
scientific image
Press Release No. 1 Berlin

Developing a CRISPR therapy for muscular dystrophy

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular dystrophy with the help of gene-editing. Preclinical research led by the Spuler Lab published in “Nature Communications” now paves the way for first-in-human clinical trials.
Simon Haas
Science

BBAW Prize for cancer researcher Simon Haas

Simon Haas has been awarded the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) Prize for the promotion of cancer research, sponsored by the Monika Kutzner Foundation. His outstanding research focuses on the causes and the development of new concepts for the treatment of blood cancer.
Scientific image
Press Release No. 32 Berlin

Cancer risk linked to p53 in Ulcerative Colitis

Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité – Universitätsmedizin Berlin have elucidated the role of the p53 gene in ulcerative colitis. The study, published in “Science Advances,” suggests a potential new drug target to stop disease progression to cancer.